Structural Formula (Image 1)
Cyclobenzaprine Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2514
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 71335-2514). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Image 2)
Image (Image 3)
Image (Image 4)
Image (Image 5)
Image (Image 6)
Image (Image 7)
Label (Lbl713352514)
This is a description of an extended-release capsule medication containing 15 mg of Cyclobenzaprine Hydrochloride intended for adults. The recommended dosage is 1 or 2 capsules taken once daily at the same time each day. The capsules should be stored at 25°C (77°F) with excursions allowed between 15° to 30°C (59° to 86°F). The medication should be kept out of reach of children and dispensed in a tight, light-resistant container. The product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by TWi Pharmaceuticals, Inc. Additional information can be accessed by scanning the QR code on the package.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
